Mice as clinically relevant models for the study of cytochrome P450-dependent metabolism

被引:53
作者
Muruganandan, S. [1 ]
Sinal, C. J. [1 ]
机构
[1] Dalhousie Univ, Dept Pharmacol, Halifax, NS B3H 4H7, Canada
关键词
D O I
10.1038/clpt.2008.50
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The cytochrome P450 (CYP) gene superfamily comprises a large group of hemoproteins with diverse functions in steroid, lipid, and xenobiotic metabolism. The human genome is estimated to contain 57 genes that encode functional CYP proteins, a number of which are important for the metabolism of foreign chemicals, including carcinogens and most therapeutic drugs. Given that metabolic interactions are a major source of adverse drug interactions, a comprehensive understanding of CYP function is critically important for the development and safe clinical application of drugs. While some cross-species genetic conservation of CYPs exists, drug metabolism can differ between humans and other mammalian species. The development of humanized mice that replicate many aspects of human drug metabolism has provided invaluable experimental models that circumvent this limitation to a considerable degree. This brief review focuses on the value and limitations of mouse models for the study of drug metabolism in humans.
引用
收藏
页码:818 / 828
页数:11
相关论文
共 50 条
[1]   Determining the best animal model for human cytochrome P450 activities: a comparison of mouse, rat, rabbit, dog, micropig, monkey and man [J].
Bogaards, JJP ;
Bertrand, M ;
Jackson, P ;
Oudshoorn, MJ ;
Weaver, RJ ;
van Bladeren, PJ ;
Walther, B .
XENOBIOTICA, 2000, 30 (12) :1131-1152
[2]   Acetone catabolism by cytochrome P450 2E1: Studies with CYP2E1-null mice [J].
Bondoc, FY ;
Bao, ZP ;
Hu, WY ;
Gonzalez, FJ ;
Wang, YY ;
Yang, CS ;
Hong, JY .
BIOCHEMICAL PHARMACOLOGY, 1999, 58 (03) :461-463
[3]   Oxidative stress, toxicology, and pharmacology of CYP2E1 [J].
Caro, AA ;
Cederbaum, AI .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2004, 44 :27-42
[4]   Growth hormone determines sexual dimorphism of hepatic cytochrome P450 3A4 expression in transgenic mice [J].
Cheung, C ;
Yu, AM ;
Chen, CS ;
Krausz, KW ;
Byrd, LG ;
Feigenbaum, L ;
Edwards, RJ ;
Waxman, DJ ;
Gonzalez, FJ .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 316 (03) :1328-1334
[5]   Differential metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in mice humanized for CYP1A1 and CYP1A2 [J].
Cheung, C ;
Ma, XC ;
Krausz, KW ;
Kimura, S ;
Feigenbaum, L ;
Dalton, TP ;
Nebert, DW ;
Idle, JR ;
Gonzalez, FJ .
CHEMICAL RESEARCH IN TOXICOLOGY, 2005, 18 (09) :1471-1478
[6]   The CYP2E1-humanized transgenic mouse:: Role of CYP2E1 in acetaminophen hepatotoxicity [J].
Cheung, C ;
Yu, AM ;
Ward, JM ;
Krausz, KW ;
Akiyama, TE ;
Feigenbaum, L ;
Gonzalez, FJ .
DRUG METABOLISM AND DISPOSITION, 2005, 33 (03) :449-457
[7]   How many deaths occur annually from adverse drug reactions in the United States? [J].
Chyka, PA .
AMERICAN JOURNAL OF MEDICINE, 2000, 109 (02) :122-130
[8]   The CYP2D6 humanized mouse:: Effect of the human CYP2D6 transgene and HNF4α on the disposition of debrisoquine in the mouse [J].
Corchero, J ;
Granvil, CP ;
Akiyama, TE ;
Hayhurst, GP ;
Pimprale, S ;
Feigenbaum, L ;
Idle, JR ;
Gonzalez, FJ .
MOLECULAR PHARMACOLOGY, 2001, 60 (06) :1260-1267
[9]   Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus [J].
Dandri, M ;
Burda, MR ;
Török, E ;
Pollok, JM ;
Iwanska, A ;
Sommer, G ;
Rogiers, X ;
Rogler, CE ;
Gupta, S ;
Will, H ;
Greten, H ;
Petersen, J .
HEPATOLOGY, 2001, 33 (04) :981-988
[10]   Theophylline pharmacokinetics:: comparison of Cyp1a1(-/-) and Cyp1a2(-/-) knockout mice, humanized hCYP1A1_1A2 knock-in mice lacking either the mouse Cyp1a1 or Cyp1a2 gene, and Cyp1(+/+) wild-type mice [J].
Derkenne, S ;
Curran, CP ;
Shertzer, HG ;
Dalton, TP ;
Dragin, N ;
Nebert, DW .
PHARMACOGENETICS AND GENOMICS, 2005, 15 (07) :503-511